Prostate Cancer: Public Comment on Draft Report

Public comments received on ICER’s Draft Evidence Report on treatments for high risk prostate cancer.

View

View All Materials on this Topic or Go Back to View More Materials

EMAIL SIGNUP

Stay up-to-date on the latest news from ICER.
© ICER, 2020.

CONTACT US

Institute for Clinical and Economic Review
Two Liberty Square, Ninth Floor, Boston, MA 02109
Get directions.

(617) 528-4013

STAY CONNECTED

To ensure that our reports are as useful as possible to our stakeholders, we would like to get a better sense of how they are being used. You will be redirected to the report after answering these brief questions.

Which category best describes your perspective?*
Other
How do you intend to use this material*
Please check all that apply.
- To inform treatment decisions or guidelines
- To inform state policy
- To inform federal policy
- To inform public comment/feedback to ICER
- To inform coverage decisions and contracting policies
- To inform pricing
- Other
If Other, please describe

We use cookies to ensure that we give you the best experience on our website. By closing this banner, scrolling this page, clicking a link, or continuing to browse this site, you agree to this use.Ok Privacy policy